Advanced search
Publication Cover
Expert Review of Anti-infective Therapy Volume 2, 2004 - Issue 4
Submit an article Journal homepage
40
Views
24
CrossRef citations to date
0
Altmetric
Review

Chronic Pseudomonas aeruginosa infection in cystic fibrosis airway disease: metabolic changes that unravel novel drug targets

Sang Sun Yoon Department of Molecular Genetics, Biochemistry and Microbiology, University of Cincinnati College of Medicine, 231 Albert Sabin Way, Cincinnati, OH 45267 0524, USA. [email protected]
&
Daniel J Hassett Department of Molecular Genetics, Biochemistry and Microbiology, University of Cincinnati College of Medicine, 231 Albert Sabin Way, Cincinnati, OH 45267 0524, USA. [email protected]
Pages 611-623 | Published online: 10 Jan 2014

References

  • Ratjen F, Doring G. Cystic fibrosis. Lancet 361, 681–689 (2003).
  • Meyer KC, Zimmerman J. Neutrophil mediators, pseudomonas, and pulmonary dysfunction in cystic fibrosis. J. Lab. Clin. Med. 121, 654–661 (1993).
  • Jagger KS, Robinson DL, Franz MN, Warren RL. Detection by enzyme-linked immunosorbent assays of antibody specific for pseudomonas proteases and exotoxin A in sera from cystic fibrosis patients. J. Clin. Microbial. 15, 1054–1058 (1982).
  • Su W, Porter S, Kustu S, Echols H. DNA-looping and enhancer activity — association between DNA-bound Ntrc activator and RNA polymerase at the bacterial Gina promoter. Proc. Nad Acad. Sci. USA 87, 5504–5508 (1990).
  • Erwin AL, VanDevanter DR The Pseudomonas aeruginosa genome: how do we use it to develop strategies for the treatment of patients with cystic fibrosis and pseudomonas infections? Curr Opin. Pulm. Med 8, 547–551 (2002).
  • Stotland PK, Raclzioch D, Stevenson MM. Mouse models of chronic lung infection with Pseudomonas aeruginosa: models for the study of cystic fibrosis. Pediatn Pulmonol 30, 413–424 (2000).
  • Tarran R, Grubb BR, Parsons D, et al. The CF salt controversy: in vivo observations and therapeutic approaches. Mal Cell 8, 149–158 (2001).
  • Vasil ML Pseudomonas aeruginosa: biology, mechanisms of virulence, epidemiology. Pediatn 108, 800–805 (1986).
  • Campa M, Bendinelli M, Friedman H (Eds), Pseudomonas aeruginosa as an Opportunistic Pathogen. Plenum Press, NY, USA (1993).
  • Greenberg ER Bacterial genomics. Pump up the versatility. Nature 406,947–948 (2000).
  • Bayley SA, Morris DW, Broda R The relationship of degradative and resistance plasmids of Pseudomonas belonging to the same incompatibility group. Nature 280, 338–339 (1979).
  • Ingram JM, Hassan HM. The resistance of Pseudomonas aeruginosa to chloramphenicol. Can. J. Microbial 21,1185–1191 (1975).
  • Knothe H, Krcmery V. Apparent antagonism by a resident R plasmid for entry of related gentamicin—tobramycin resistance plasmids in Pseudomonas aeruginosa. Chemotherapy 21, 281–283 (1975).
  • Olsen RH, Hansen J. Evolution and utility of a Pseudomonas aeruginosa drug resistance factor. J. Bacterial 125,837–844 (1976).
  • Stover CK, Pham XQ, Erwin AL, et al. Complete genome sequence of Pseudomonas aeruginosa PA01, an opportunistic pathogen. Nature 406, 959–964 (2000).
  • Stewart PS. Mechanisms of antibiotic resistance in bacterial biofilms. Int. J Med. Microbial 292,107–113 (2002).
  • de Kievit TR, Iglewski BH. Bacterial quorum sensing in pathogenic relationships. Infect. Immun. 68,4839–4849 (2000).
  • Parsek MR, Greenberg ER Quorum sensing signals in development of Pseudomonas aeruginosa biofilms. Methods Enzymol 310,43–55 (1999).
  • Singh PK, Schaefer AL, Parsek MR, Moninger TO, Welsh MJ, Greenberg ER Quorum-sensing signals indicate that cystic fibrosis lungs are infected with bacterial biofilms. Nature 407,762–764 (2000).
  • Hassett DJ, Cuppoletti J, Trapnell B, et al. Anaerobic metabolism and quorum sensing by Pseudomonas aeruginosa biofilms in chronically infected cystic fibrosis airways: rethinking antibiotic treatment strategies and drug targets. Adv. Drug Deliv. Rev. 54, 1425–1443 (2002).
  • Costerton JW Introduction to biofilm. Int.J.Antimicrob.Agents. 11,217–221 (1999).
  • O'Toole GA, Kolter R. Flagellar and twitching motility are necessary for Pseudomonas aeruginosa biofilm development. Mal Microbial 30,295–304 (1998).
  • Wolfaardt GM, Lawrence JR, Robarts RD, Caldwell DE. The role of interactions, sessile growth and nutrient amendments on the degradative efficiency of a microbial consortium. Can. J. Microbial 40,331–340 (1994).
  • Boyd A, Chakrabarty AM. Pseudomonas aeruginosa biofilms: role of the alginate exopolysaccharide. J Ind Microbial 15,162–168 (1995).
  • Davey ME, Caiazzn NC, O'Toole GA. Rhamnolipid surfactant production affects biofilm architecture in Pseudomonas aeruginosa PA01. J. Bacterial 185,1027–1036 (2003).
  • Hentzer M, Teitzel GM, Balzer GJ, et al. Alginate overproduction affects Pseudomonas aeruginosa biofilm structure and function. Bacterial 183,5395–5401 (2001).
  • Hassett DJ, Ma J-F, Elkins JG, et al. Quorum sensing in Pseudomonas aeruginosa controls expression of catalase and superoxide dismutase genes and mediates biofilm susceptibility to hydrogen peroxide. Mal Microbial 34,1082–1093 (1999).
  • Anwar H, Dasgupta M, Lam K, Costerton JW Tobramycin resistance of mucoid Pseudomonas aeruginosa biofilm grown under iron limitation. J. Antimicrob. Chemother 24, 647–655 (1989).
  • Coquet L, Junter GA, Jouenne T Resistance of artificial biofilms of Pseudomonas aeruginosa to imipenem and tobramycin. J. Antimicrob. Chemother. 42,755–760 (1998).
  • Nickel JC, Ruseska I, Wright JB, Costerton JW Tobramycin resistance of Pseudomonas aeruginosa cells growing as a biofilm on urinary catheter material. Antimicrob. Agents Chemother. 27,619–624 (1985).
  • Evans DJ, Allison DG, Brown MR, Gilbert R Susceptibility of Pseudomonas aeruginosa and Escherichia coli biofilms towards ciprofloxacin: effect of specific growth rate. J Antimicrob. Chemother. 27,177–184 (1991).
  • Teitzel GM, Parsek MR Heavy metal resistance of biofilm and planktonic Pseudomonas aeruginosa. Appl Environ. Microbial 69,2313–2320 (2003).
  • Suci PAMW Yu FR Geesey GG, Mittelman. Investigation of ciprofloxacin penetration into Pseudomonas aeruginosa biofilms. Antimicrob. Agents Chemother 38,2125–2133 (1994).
  • Tanaka K, Takahashi H. Cloning, analysis and expression of an loShomolog gene from Pseudomonas aeruginosa PA01. Gene 150, 81–85 (1994).
  • Xu KD, Franklin MJ, Park CH, McFeters GA, Stewart PS. Gene expression and protein levels of the stationary phase sigma factor, RpoS, in continuously-fed Pseudomonas aeruginosa biofilms. FEMS Microbial Lett. 199,67-71 (2001). 36Heydom A, Ersboll B, Kato J, et al. Statistical analysis of Pseudomonas aeruginosa biofilm development: impact of mutations in genes involved in twitching motility, cell-to-cell signaling, and stationary-phase a-factor expression. Appl Environ. Microbial 68, 2008–2017 (2002).
  • Whiteley M, Bangera MG, Bumgarner RE, etal. Gene expression in Pseudomonas aeruginosa biofilms. Nature 413,860–864 (2001).
  • Suh SJ, Silo-Suh L, Woods DE, et al. Effect of loS mutation on the stress response and expression of virulence factors in Pseudomonas aeruginosa. J Bacterial 181, 3890–3897 (1999).
  • Rashid MH, Rumbaugh K, Passador L, et al. Polyphosphate kinase is essential for biofilm development, quorum sensing, and virulence of Pseudomonas aeruginosa. Proc. Natl Acad Sci. USA 97,9636–9641 (2000).
  • Davies DG, Parsek MR, Pearson JP, Iglewski BH, Costerton JW, Greenberg ER The involvement of cell-to-cell signals in the development of a bacterial biofilm. Science 280,295–298 (1998).
  • O'Toole GA, Gibbs KA, Hager PW, Phibbs PV Jr, Kolter R The global carbon metabolism regulator Crc is a component of a signal transduction pathway required for biofilm development by Pseudomonas aeruginosa. J Bacterial 182, 425–31 (2000).
  • Parkins MD, Ceri H, Storey DG. Pseudomonas aeruginosa GacA, a factor in multihost virulence, is also essential for biofilm formation. Mal Microbial 40, 1215–1226 (2001).
  • Finelli A, Gallant CV, Jarvi K, Burrows LL. Use of in-biofilm expression technology to identify genes involved in Pseudomonas aeruginosa biofilm development. J. Bacterial 185,2700–2710 (2003).
  • Mah TF, Pitts B, Pellock B, et al. A genetic basis for Pseudomonas aeruginosa biofilm antibiotic resistance. Nature 426,306–310 (2003).
  • Xu KD, Stewart PS, Xia F, Huang CT, McFeters GA. Spatial physiological heterogeneity in Pseudomonas aeruginosa biofilm is determined by oxygen availability. Appl Environ. Microbial 64,4035–4039 (1998).
  • Worlitzsch D, Tarran R, Ulrich M, et al. Reduced oxygen concentrations in airway mucus contribute to the early and late pathogenesis of Pseudomonas aeruginosa cystic fibrosis airway infction.J. Clin. Invest. 109, 317–325 (2002).
  • Yoon SS, Hennigan RE Hilliard GM, et al . Pseudomonas aeruginosa anaerobic respiration in biofilms: relationships to cystic fibrosis pathogenesis. Dev. Cell 3,593–603 (2002).
  • Rumbaugh KP, Griswold JA, Hamood AN. The role of quorum sensing in the in vivo virulence of Pseudomonas aeruginosa. Microbes Infect. 2,1721–1731 (2000).
  • Smith RS, Iglewski BH. Pseudomonas aeruginosa quorum-sensing systems and virulence. Curr Opin. Microbial 6,56–60 (2003).
  • Nealson KH, Platt T, Hastings JW Cellular control of the synthesis and activity of the bacterial luminescent system. J Bacterial 104, 313–322 (1970).
  • Gambello MJ, Iglewski BH. Cloning and characterization of the Pseudomonas aeruginosa lasR gene, a transciptional activator of elastase expression. J Bacterial 173,3000–3009 (1991).
  • Ochsner UA, Fiechter A, Reiser J. Isolation, characterization, and expression in Escherichia coli of the Pseudomonas aeruginosa rhIAB genes encoding a rhamnosyltransferase involved in rhamnolipid biosurfactant synthesis. J. Bid Chem. 269,19787–19795 (1994).
  • Storey DG, Ujack EE, Rabin HR, Mitchell I. Pseudomonas aeruginosa lasR transcription correlates with the transcription of lasA,lasB, and tozA in chronic lung infections associated with cystic fibrosis. Infict Immun. 66, 2521–2528 (1998).
  • Jones S, Yu B, Bainton A, et al. The lux autoinducer regulates the production of exoenzyme virulence determinants in Erwinia carotovora and Pseudomonas aeruginosa. Embo. J 12,2477–2482 (1993).
  • Howe TR, Iglewski BH. Isolation and characterization of alkaline protease-deficient mutants of Pseudomonas aeruginosa in vitro and in a mouse eye model. Infect. Immun. 43, 1058–1063 (1984).
  • Ochsner UA, Reiser J. Autoinducer-mediated regulation of rhamnolipid biosurfactant synthesis in Pseudomonas aeruginosa. Proc. Nad Acad. Sci. USA 92,6424–6428 (1995).
  • Pearson JP, Pesci EC, Igkewski BH. Roles of Pseudomonas aeruginosa las and rhl quorum-sensing systems in control of elastase and rhamnolipid biosynthesis genes. J Bacterial 179,5756–5767 (1997).
  • Rumbaugh KB, Griswold JA, Iglewski BH, Hamood AN. Contribution of quorum sensing to the virulence of Pseudomonas aeruginosa in burn wound infections. Infict Immun. 67,5854–5862 (1999).
  • Tang HB, DiMango E, Bryan R, et al. Contribution of specific Pseudomonas aeruginosa virulence factors to pathogenesis of pneumonia in a neonatal mouse model of infection. Infict Immun. 64, 37–43 (1996).
  • Smith RS, Fedyk ER, Springer TA, Mukaida N, Iglewski BH, Phipps RR IL-8 production in human lung fibroblasts and epithelial cells activated by the pseudomonas autoinducer N-3-oxododecanoyl homoserine lactone is transcriptionally regulated by NF-KB and activator protein-2.j Immund 167, 366–374 (2001).
  • Erickson DL, Endersby R, Kirkham A, et al. Pseudomonas aeruginosa quorum-sensing systems may control virulence factor expression in the lungs of patients with cystic fibrosis. Infect. Immun. 70,1783–1790 (2002).
  • Middleton B, Rodgers HC, Camara M, Knox AJ, Williams P, Hardman A. Direct detection of N-acylhomoserine lactones in cystic fibrosis sputum. FEMS Microbial Lett. 207,1-7 (2002).
  • Whiteley M, Lee 1KI\4, Greenberg ER Identification of genes controlled by quorum sensing in Pseudomonas aeruginosa. Proc. Nad Acad Sci. 96,13904–13909 (1999).
  • Schuster M, Lostroh CP, Ogi T, Greenberg ER Identification, timing, and signal specificity of Pseudomonas aeruginosa quorum-controlled genes: a transcriptome analysis. J. Bacterial 185,2066–2079 (2003).
  • Wagner VE, Bushnell D, Passador L, Brooks AT, Iglewski BH. Microarray analysis of Pseudomonas aeruginosa quorum-sensing regulons: effects of growth phase and environment. J. Bacterial 185,2080–2095 (2003).
  • Evans LR, Linker A. Production and characterization of the slime polysaccharide of Pseudomonas aeruginosa. J Bacterial 116, 915–924 (1973).
  • Chitnis CE, Ohman DE. Cloning of Pseudomonas aeruginosa algG, which controls alginate structure. J. Bacterial 172,2894-2900 (1990).
  • Garrett ES, Perlegas D, Wozniak DJ. Negative control of flagellum synthesis in Pseudomonas aeruginosa is modulated by the alternative sigma factor AlgT (AlgU). J. Bacterial 181,7401–7404 (1999).
  • Hassett DJ. Anaerobic production of alginate by Pseudomonas aeruginosa: alginate restricts diffusion of oxygen. J Bacterial 178, 7322–7325 (1996).
  • Wyckoff TJ, Thomas B, Hassett DJ, Wozniak DJ. Static growth of mucoid Pseudomonas aeruginosa selects for nonmucoid variants that have acquired flagellum-dependent motility. Microbiology 148, 3423–3430 (2002).
  • Martin DW, Schurr MJ, Mudd MH, Deretic V Mechanism of conversion to mucoidy in Pseudomonas aeruginosa infecting cystic fibrosis patients. Proc. Nad Acad Sci. USA 90,8377–8381 (1993).
  • Mathee K0, Sternberg C, Ciofu , et al . Mucoid conversion of Pseudomonas aeruginosa by hydrogen peroxide: a mechanism for virulence activation in the cystic fibrosis lung. Microbiology 145,1349–1357 (1999).
  • Bayer AS, Park S, Ramos MC, Nast CC, Eftekhar F, Schiller NIL. Effects of alginase on the natural history and antibiotic therapy of experimental endocarditis caused by mucoid Pseudomonas aeruginosa. Infia. Immun. 60, 3979–3985 (1992).
  • Cabral DA, Loh BA, Speert DR Mucoid Pseudomonas aeruginosa resists nonopsonic phagocytosis by human neutrophils and macrophages. Pediatr. Res. 22,429–431 (1987).
  • Eftekhar F, Speert DR Alginase treatment of mucoid Pseudomonas aeruginosa enhances phagocytosis by human monocyte-derived macrophages. Infect. Immun. 56,2788–2793 (1988).
  • Krieg DP, Bass JA, Mattingly SJ. Phosphorylcholine stimulates capsule formation of phosphate-limited mucoid Pseudomonas aeruginosa. InjQc. Immun. 56, 864–873 (1988).
  • Meshulam T, Obedeanu N, Merzbach D, Sobel JD. Phagocytosis of mucoid and nonmucoid strains of Pseudomonas aeruginosa. Clin. Immund Immunopathol 32,151–165 (1984).
  • Oliver AM, Weir DM. Inhibition of bacterial binding to mouse macrophages by Pseudomonas alginate. J. Clin. Lab. Immund 10,221–224(1983).
  • Simpson JA, Smith SE, Dean RT. Alginate inhibition of the uptake of Pseudomonas aeruginosa by macrophages. J Gen. Microbial 134,29–36 (1988).
  • Hazlett LD, Rudner XL. Investigations on the role of flagella in adhesion of Pseudomonas aeruginosa to mouse and human corneal epithelial proteins. Ophthalmic Res. 26,375–379 (1994).
  • Lillehoj EP, Kim BT, Kim KC. Identification of Pseudomonas aeruginosa flagellin as an adhesin for Mud/ mucin. Am. J. Physiol Lung Cell Mal Physiol 282, L751—L756 (2002).
  • Mahenthiralingam E, Speert DR Nonopsonic phagocytosis of Pseudomonas aeruginosa by macrophages and polymorphonuclear leukocytes requires the presence of the bacterial flagellum. Infect. Immun. 63,4519–4523 (1995).
  • Sanjar S. Measurement and pharmacology of mucociliary clearance. Agents Actions 34(Suppl.), 457–470 (1991).
  • Armengot M, Escribano A, Carda C,, et al. Nasal mucociliary transport and ciliary ultrastructure in cystic fibrosis. A comparative study with healthy volunteers. Int. J Pediatr. OtorhinolagngoL 40,27–34 (1997).
  • Cowley EA, Wang CG, Gosselin D, Radzioch D, Eidelman DH. Mucociliary clearance in cystic fibrosis knockout mice infected with Pseudomonas aeruginosa. Eur Respir. J 10, 2312–2318 (1997).
  • Regnis JA, Robinson M, Bailey DL, et al. Mucociliary clearance in patients with cystic fibrosis and in normal subjects. Am. J Respir Crit. Carr Med 150,66–71 (1994).
  • Doring G, Worlitzsch D. Inflammation in cystic fibrosis and its management. Paediatr. Respir Rev. 1, 101–106 (2000).
  • Imundo L, Barasch J, Prince A, Al-Awqati Q Cystic fibrosis epithelial cells have a receptor for pathogenic bacteria on their apical surface. Proc. Nad Acad Sci. USA 92,3019–3023 (1995).
  • Pier GB, Grout M, Zaidi TS, et al. Role of mutant CFTR in hypersusceptibility of cystic fibrosis patients to lung infections. Science 271,64–67(1996).
  • Schroeder TH, Lee MM, Yacono PW, et al. CFTR is a pattern recognition molecule that extracts Pseudomonas aeruginosa LPS from the outer membrane into epithelial cells and activates NF-KB translocation. Proc. Nail Acad Sci. USA 99,6907–6912 (2002).
  • Bals R, Weiner DJ, Wilson JM. The innate immune system in cystic fibrosis lung disease. J. Clin. Invest. 103,303–307 (1999).
  • Farinas J, Kneen M, Moore M, Verkman AS. Plasma membrane water permeability of cultured cells and epithelia measured by light microscopy with spatial filtering. J. Gen. PhysioL 110,283–296(1997).
  • Matsui H, Grubb BR, Tarran R, et al. Evidence for periciliary liquid layer depletion, not abnormal ion composition, in the pathogenesis of cystic fibrosis airways disease. Ce// 95,1005–1015 (1998).
  • Smith JJ, Travis SM, Greenberg EP, Welsh MJ. Cystic fibrosis airway epithelia fail to kill bacteria because of abnormal airway surface fluid. Cell 85,229–236 (1996).
  • Zabner J, Smith JJ, Karp PH, Widdicombe JH, Welsh MJ. Loss of CFTR chloride channels alters salt absorption by cystic fibrosis airway epithelia in vitro. MoL Cell 2, 397–403 (1998).
  • Lehrer RI, Lichtenstein AK, Ganz T Defensins: antimicrobial and cytotoxic peptides of mammalian cells. Ann. Rev. ImmunoL 11, 105–128 (1993).
  • Martin E, Ganz T, Lehrer RI. Defensins and other endogenous peptide antibiotics of vertebrates. J Leukoc. Biol. 58,128–36 (1995).
  • Cole AM, Dewan P, Ganz T Innate antimicrobial activity of nasal secretions. Infect. Immun. 67,3267–3275 (1999).
  • Willumsen NJ, Davis CW, Boucher RC. Cellulartransport in cultured cysticfibrosis airway epithelium. Am. J PhysioL 256, C1045—C1053 (1989).
  • Caldwell RA, Grubb BR, Tarran R, Boucher RC, Knowles MR, Barker PM. In vivo airway surface liquid Ct analysis with solid-state electrodes. J. Gen. PhysioL 119,3–14(2002).
  • Grubb BR, Chadburn JL, Boucher RC. In vivo microdialysis for determination of nasal liquid ion composition. Am. J PhysioL CelL PhysioL 282, C1423—C1431 (2002).
  • Wasser IM, de Vries S, Moenne-Loccoz P, Schroder I, Karlin KD. Nitric oxide in biological denitrification: Fe/Cu metalloenzyme and metal complex NO(x) redox chemistry. Chem. Rev. 102,1201–1234 (2002).
  • Jones KL, Hegab AH, Hillman F, et al. Elevation of nitrotyrosine and nitrate concentrations in cystic fibrosis sputum. Pediatr PulmonoL 30,79–85 (2000).
  • Rosenfeld M, Gibson RL, McNamara S, et al. Early pulmonary infection, inflammation, and clinical outcomes in infants with cystic fibrosis. Pediatr PulmonoL 32,356–66 (2001).
  • Khan TZ, Wagener JS, Bost T, Martinez J, Accurso FJ, Riches DW. Early pulmonary inflammation in infants with cystic fibrosis. Am. J Respir. Crit. Care Med 151, 1075–1082 (1995).
  • Balough K, McCubbin M, Weinberger M, Smits W, Ahrens R, Fick R The relationship between infection and inflammation in the early stages of lung disease from cystic fibrosis. Ped PulmonoL 20,63–70 (1995).
  • Zahm JM, Gaillard D, Dupuit F, et al. Early alterations in airway mucociliary clearance and inflammation of the lamina propria in CF mice. Am. J PhysioL 272, C853—C859 (1997).
  • Muhlebach MS, Noah U. Endotoxin activity and inflammatory markers in the airways of young patients with cystic fibrosis. Am. J Respir. Crit. Care Med 165,911–915 (2002).
  • Bonfield TL, Konstan MW, Burfeind P, Panuska JR, Hilliard JM, Berger P. Normal bronchial epithelial cells constitutively produce the anti-inflammatory cytokine interleukin-10, which is downregulated in cystic fibrosis. Am. J Respir CelL MoL BioL 13,257–261 (1995).
  • Chmiel JF, Konstan MW, Knesebeck JE, et al. IL-10 attenuates excessive inflammation in chronic pseudomonas infection in mice. Am. J. Respir Crit. Carr Med. 160,2040–2047 (1999).
  • Egan ME, Pearson M, Weiner SA, et al. Curcumin, a major constituent of turmeric, corrects cystic fibrosis defects. Science 304, 600–602 (2004).
  • Snouwaert JN, Brigman KK, Latour AM, et al. An animal model for cystic fibrosis made by gene targeting. Science 257,1083–1088 (1992).
  • Thou L, Dey CR, Wert SE, DuVall MD, Frizzell RA, Whitsett JA. Correction of lethal intestinal defect in a mouse model of cystic fibrosis by human CFTR Science 266, 1705–1708 (1994).
  • Mall M, Grubb BR, Harkema JR, O'Neal WK, Boucher RC. Increased airway epithelial Na+ absorption produces cystic fibrosis-like lung disease in mice. Nature Med 10, 487–493 (2004).
  • Boucher, RC. Status of gene therapy for cystic fibrosis lung disease. J. Clin. Invest. 103, 441–445 (1999).
  • DeVries CA, Ohman DE. Mucoid-to-nonmucoid conversion in alginate-producing Pseudomonas aeruginosa often results from spontaneous mutations in algl; encoding a putative alternate a-factor, and shows evidence for autoregulation. J BacterioL 176, 6677–6687 (1994).

Websites

  • The Pseudomonas Genome Project www.pseudomonas.com (Accessed July 2004)

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.